These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 3326081)

  • 1. Intravenous platelet activating factor does not affect lung epithelial permeability.
    Bloom JW; Quan SF; Halonen M; Witten ML; Lemen RJ; Patton DD
    Res Commun Chem Pathol Pharmacol; 1987 Dec; 58(3):405-8. PubMed ID: 3326081
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of intravenous and aerosolized arachidonic acid on alveolar epithelial permeability in rabbits.
    Stevenson JL; Quan SF; Witten ML; Hall JN; Roseberry HR; McNeill GC; Lemen RJ
    Res Commun Chem Pathol Pharmacol; 1991 Apr; 72(1):113-6. PubMed ID: 1905059
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hydrogen peroxide-induced increase in lung endothelial and epithelial permeability--effect of adenylate cyclase stimulation and phosphodiesterase inhibition.
    Seeger W; Hansen T; Rössig R; Schmehl T; Schütte H; Krämer HJ; Walmrath D; Weissmann N; Grimminger F; Suttorp N
    Microvasc Res; 1995 Jul; 50(1):1-17. PubMed ID: 7476570
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High alveolar surface tension increases clearance of technetium 99m diethylenetriamine-pentaacetic acid.
    Nieman G; Ritter-Hrncirik C; Grossman Z; Witanowski L; Clark W; Bredenberg C
    J Thorac Cardiovasc Surg; 1990 Jul; 100(1):129-33. PubMed ID: 1694937
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Platelet-activating factor increases pulmonary microvascular permeability and induces pulmonary edema. A preliminary report.
    Mojarad M; Hamasaki Y; Said SI
    Bull Eur Physiopathol Respir; 1983; 19(3):253-6. PubMed ID: 6882949
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pulmonary clearance of 99mTc-DTPA. An index of alveolar epithelial permeability.
    Groth S
    Dan Med Bull; 1991 Jun; 38(3):189-203. PubMed ID: 1868751
    [No Abstract]   [Full Text] [Related]  

  • 7. Pulmonary epithelial permeability in hyaline-membrane disease.
    Jefferies AL; Coates G; O'Brodovich H
    N Engl J Med; 1984 Oct; 311(17):1075-80. PubMed ID: 6384782
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Permeability changes in bronchiolo-alveolar epithelium].
    Kanazawa M
    Nihon Kyobu Shikkan Gakkai Zasshi; 1989 May; 27(5):556-60. PubMed ID: 2693786
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pulmonary epithelial permeability in ARDS and cardiogenic pulmonary oedema.
    Todisco T; Dottorini M; Rossi F; Baldoncini A; Palumbo R
    Eur Respir J; 1988 Dec; 1(10):918-22. PubMed ID: 3066642
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The contribution of lymphatic drainage to the clearance of inhaled 99mTc-DTPA from the lungs.
    Coates G; O'Brodovich HM
    Clin Invest Med; 1986; 9(1):15-20. PubMed ID: 3514019
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Platelet-activating factor and bacteremia-induced pulmonary hypertension.
    Clavijo LC; Carter MB; Matheson PJ; Wills-Frank LA; Wilson MA; Wead WB; Garrison RN
    J Surg Res; 2000 Feb; 88(2):173-80. PubMed ID: 10644485
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of inhalation of platelet-activating factor on the pulmonary clearance of 99mTc-DTPA aerosol.
    Mason GR; Peters AM; Myers MJ; Ind PW; Hughes JM
    Am J Respir Crit Care Med; 1995 May; 151(5):1621-4. PubMed ID: 7735622
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of platelet-activating factor on lung epithelial permeability in the guinea-pig.
    Macquin-Mavier I; Franco-Montoya ML; Rosso J; Jarreau PH; Meignan M; Harf A
    Pulm Pharmacol; 1991; 4(4):233-8. PubMed ID: 1806136
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of pulmonary alveolar epithelial integrity by the detection of restriction to diffusion of hydrophilic solutes of different molecular sizes.
    Mason GR; Peters AM; Bagdades E; Myers MJ; Snook D; Hughes JM
    Clin Sci (Lond); 2001 Mar; 100(3):231-6. PubMed ID: 11222107
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New developments in the pathogenesis of smoke inhalation-induced pulmonary edema.
    Witten ML; Quan SF; Sobonya RE; Lemen RJ
    West J Med; 1988 Jan; 148(1):33-6. PubMed ID: 3277334
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of inhaled furosemide on lung clearance of technetium-99m-DTPA.
    Inoue T; Shigeta M; Mochizuki H; Shimizu T; Morikawa A; Suzuki H; Watanabe N; Tateno M; Oriuchi N; Hirano T
    J Nucl Med; 1995 Jan; 36(1):73-7. PubMed ID: 7799087
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cutaneous and pulmonary histopathological responses to platelet activating factor (Paf-acether) in the guinea-pig.
    Dewar A; Archer CB; Paul W; Page CP; MacDonald DM; Morley J
    J Pathol; 1984 Sep; 144(1):25-34. PubMed ID: 6481526
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pulmonary permeability in primary ciliary dyskinesia.
    Groth S; Pedersen M
    Eur Respir J; 1989 Jan; 2(1):64-70. PubMed ID: 2651149
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibitor effect of apafant on bronchopulmonary responses to platelet activating factor and to antigen in rats.
    Akagi M; Nishioka E; Kanoh R; Tachibana M; Fukuishi N
    Arzneimittelforschung; 1997 Dec; 47(12):1364-9. PubMed ID: 9450165
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic thromboembolic occlusion of main pulmonary artery does not reduce the lung clearance of 99mTc-DTPA.
    Meignan M; Rosso J
    Am Rev Respir Dis; 1989 Jun; 139(6):1536-8. PubMed ID: 2658704
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.